Moraes, F.C.A.d.; Sano, V.K.T.; Lôbo, A.d.O.M.; Kelly, F.A.; Morbach, V.; Pasqualotto, E.; Burbano, R.M.R.
Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials. J. Pers. Med. 2024, 14, 360.
https://doi.org/10.3390/jpm14040360
AMA Style
Moraes FCAd, Sano VKT, Lôbo AdOM, Kelly FA, Morbach V, Pasqualotto E, Burbano RMR.
Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials. Journal of Personalized Medicine. 2024; 14(4):360.
https://doi.org/10.3390/jpm14040360
Chicago/Turabian Style
Moraes, Francisco Cezar Aquino de, Vitor Kendi Tsuchiya Sano, Artur de Oliveira Macena Lôbo, Francinny Alves Kelly, Victória Morbach, Eric Pasqualotto, and Rommel Mario RodrÃguez Burbano.
2024. "Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials" Journal of Personalized Medicine 14, no. 4: 360.
https://doi.org/10.3390/jpm14040360
APA Style
Moraes, F. C. A. d., Sano, V. K. T., Lôbo, A. d. O. M., Kelly, F. A., Morbach, V., Pasqualotto, E., & Burbano, R. M. R.
(2024). Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical Trials. Journal of Personalized Medicine, 14(4), 360.
https://doi.org/10.3390/jpm14040360